Nucleus Genomics announces $3.5M seed round for a fresh take on genetic tests

When COVID-19 closed down most of society in 2020, Kian Sadeghi, like many of his then-classmates at the University of Pennsylvania, found himself holed up in his bedroom. He prefers it that way.  During those months at home in Brooklyn, Sadeghi filled eight spiral notebooks with research on genetic sequencing, computer science and statistics. The […]

Proov raises $9.7M Series A for at-home ovulation testing platform

MFB Fertility, the creator of a suite of at-home pregnancy-related hormone tests, announced a $9.7 million Series A round this week. The round follows several milestones for the company including an FDA premarket approval for a progesterone urine test and the rollout of a mobile app. It also gives the company more fodder to build […]

H1 closes $100M Series C on the back of ‘incredible traction’ and a successful first use case

Fresh off of a $58 million Series B round, and just one year after graduating from Y combinator, H1, a “LinkedIn for the healthcare industry” has raised even more cash. On Tuesday, the company announced a $100 million Series C round. The concept behind H1 is simple: It’s an increasingly rich database of medical expertise. […]

Nirvana Health announces $7.5M seed extension to help therapists navigate a ‘new world’ of insurance

As funding pours into mental health tech, one thing remains relatively unchanged: complex insurance billing. Now, even that medieval process is starting to attract startup interest — from companies that scan claims for errors, to others looking to simplify filing itself.  Nirvana Health is one of the latter. It’s a software platform looking to smooth […]

Trialjectory on track to match 50K cancer patients with clinical trials this year: 35% are from underrepresented groups

Each year millions of people are diagnosed with cancer. Meanwhile, hundreds of clinical trials testing potential treatments are ongoing. But there’s a gap between the people who need treatment and the people who actually end up in those studies.  Women and ethnic minorities are often underrepresented in cancer trials. For example, one 2018 meta-review of […]

Immunai announces a $215M Series B as its ‘immune cell atlas’ matures

Biotech startup Immunai has been on a roll when it comes to funding. The company that set out to create an atlas of the human immune system in 2018 had raised about $80 million by February 2021. On Wednesday, the company announced another significantly larger round: a $215 million series B.  Immunai has been building […]

IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut

Shares of IsoPlexis, a company creating tools to zoom in on the flurry of protein activity surrounding a single cell, began trading on Friday. The company aims to raise about $125 million with the IPO, which will be used to build the commercial team and advance the company’s plans to play a bigger part in […]

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor

GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This series B round is a vote of confidence by investors in GraphWear’s approach: to monitor key metrics in the body, like glucose, without breaking the skin at all.  GraphWear Technologies was founded in 2015 by Rajatesh Gudibande […]